Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 486 participants.

Also called NCT07603440

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 486 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07603440
  • EU CT 2024-520414-21-00
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07603440. Randomized; no masking; primary purpose treatment. Start 2026-06-15 (anticipated); primary completion 2029-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)
Acronym
IVT-ALL-IN
Condition
Stroke
Intervention (Drug)
Intravenous administration
Intervention (Procedure)
MT alone
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct07603440
Content hash
77d450966956169cef066ce698e57dcdcbc1facfdea13c30f273b8cd0b18fcf9